Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-16

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original application for olopatadine hydrochloride (generic), manufactured by Rising Pharma Holdings, Inc., as an approved generic ophthalmic ag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)